Your Messages Inbox
Your Article Summary
See Latest ArticlesBiopharmaceuticals: Approval Trends in 2008
BioPharm, 10/23/09
The year 2008 was, like 2007, a somewhat disappointing year in terms of the number of new biopharmaceuticals approved. The year witnessed the approval of eight recombinant proteins or engineered antibody–based products in the US, and two such biopharmaceuticals in the European Union. These products included hormones, interferons, blood factors, and fusion proteins—two each—as well as one antibody–based product and a colony–stimulating factor.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
U.S. Food and Drug Administration Approves ABILIFY for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients
Bristol Myers-Squibb Company, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical and minimally invasive treatments for Peyronie's disease
Current Opinion in Urology, 11/19/09
Urinary Diversion Trends at a High Volume, Single American Tertiary Care Center
The Journal of Urology, 11/02/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Article Search
Sponsor